Second, although we found a significant link between SGLT2 inhibition and malignant neoplasms of the bronchus and lung, bladder, corpus uteri, and non-melanoma, the observed OR values were relatively small, indicating a less robust association. The gene discussed is SLC5A2; the disease is cancer.